Report summarizes global progress toward rubella and congenital rubella syndrome elimination
How close are we to wiping out rubella and its devastating birth defects?
A summary report describes global progress toward eliminating rubella and congenital rubella syndrome from 2012 to 2022.
Global health experts are tracking progress to wipe out rubella and prevent devastating birth defects like deafness and blindness in babies.
Field report describes congenital rubella syndrome cases in Florida
Florida health officials report cases of congenital rubella syndrome
A field report describes cases of congenital rubella syndrome in Florida.
Florida health officials confirm cases of congenital rubella syndrome, a rare condition causing serious birth defects, highlighting the impo…
Global rubella vaccine coverage reaches 87% of countries, but elimination achieved in only 42%
How close are we to wiping out rubella worldwide?
A global surveillance report covering 194 countries from 2000-2018 found 168 countries (87%) protect infants with rubella-containing vaccine…
While 168 countries now protect infants with rubella vaccines, only 81 have eliminated the virus entirely, leaving millions still at risk of…
Research across Rubella
Related studies from across the Rubella family.
TORCH seroprevalence 32.5% in Malaysia; CMV highest, screening urged
TORCH infections found in 32.5% of Malaysian pregnant women and infants
This meta-analysis of 19 reports estimates a 32.5% overall seroprevalence of TORCH infections among pregnant women and infants in Malaysia, …
A meta-analysis finds 32.5% of pregnant women and infants in Malaysia have been exposed to TORCH infections, with CMV most common.
GSK investigational MMRV vaccine shows comparable immunogenicity to licensed MMRV in healthy children
GSK MMRV vaccine shows comparable safety and immune response to licensed MMRV in young children
This randomized, multi-country phase II trial in 801 healthy children aged 4-6 years found that one dose of a GSK investigational MMRV vacci…
A Phase II trial in healthy children found the investigational GSK MMRV vaccine produced immune responses and safety similar to the licensed…
WHO European Region reports rubella incidence trends from 2005 to 2019
What happened to rubella in Europe over 15 years?
An observational WHO report describes rubella incidence patterns across European regions from 2005 to 2019.
A new report tracks rubella cases across Europe from 2005 to 2019, but it does not share the actual findings or specific trends for the regi…
PRIORIX vaccine recommended for measles, mumps, and rubella protection in the United States
CDC panel recommends PRIORIX vaccine for measles, mumps, and rubella protection
A recommendation for the use of PRIORIX vaccination against measles, mumps, and rubella has been issued in the United States.
A CDC advisory panel now recommends the PRIORIX vaccine as a new option alongside the familiar MMR shot for measles, mumps, and rubella prot…
Questions about Congenital Rubella Syndrome
Why did only 42% of countries achieve elimination of congenital rubella syndrome?
Only 42% of countries eliminated congenital rubella syndrome because high vaccine coverage does not automatically mean transmission is stopped, and many nations lack the surveillance and lab systems needed to prove elimination.
Full answer →Are there recent cases of congenital rubella syndrome reported in Florida?
Yes, a specific field report documents cases of congenital rubella syndrome occurring in Florida.
Full answer →How much progress has been made eliminating congenital rubella syndrome globally since 2012?
Since 2012, 87% of countries have vaccinated infants against rubella, but only 42% have fully eliminated the disease and its syndrome.
Full answer →